Researchers Scramble to Keep Dog Aging Project Alive
The National Institute on Aging may let funding lapse for a yearslong study of nearly 50,000 pet dogs, which could also offer insight into human health. (Source: NYT Health)
Source: NYT Health - January 11, 2024 Category: Consumer Health News Authors: Emily Anthes Tags: your-feed-science your-feed-health Dogs Age, Chronological Pets Longevity Dementia Amyotrophic Lateral Sclerosis American Federation for Aging Research National Institute on Aging Source Type: news
Speech Accessibility Project Now Recruiting People With ALS
The Speech Accessibility Project has expanded its recruitment and is inviting U.S. and Puerto Rican adults living with amyotrophic lateral sclerosis to participate (Source: Disabled World)
Source: Disabled World - January 5, 2024 Category: Disability Tags: Disability Events - Public Notices Source Type: news
Errratum to "Suicide among veterans with amyotrophic lateral sclerosis" - The editors.
An erratum is being issued to the article published in 2021 titled Suicide among veterans with amyotrophic lateral sclerosis.1 In this research study, investigators used data from national Veterans Health Administration electronic health records (EHR) that... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Researcher loses disability lawsuit against major science funder
A jury in Maryland today delivered a unanimous verdict in favor of the Howard Hughes Medical Institute (HHMI), finding it did not discriminate against Vivian Cheung, a disabled biologist and physician, when it failed to renew her multimillion-dollar award in 2018. The closely watched case put a spotlight on obstacles faced by disabled scientists.
Lawyer Chong Park of Ropes & Gray was successful in persuading a jury of four women and two men that HHMI and its reviewers treated Cheung like any other scientist when she competed unsuccessfully to renew her investigator award for RNA studies. At the end of an 8-day tr...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
LEXINGTON, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. VYGR, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that it has selected a lead development candidate for its superoxide dismutase 1 (SOD1)-mutated…#lexington #mass #als #voyager #sod1 #iv #tracer #voyagersod1als #g93a #alfredwsandrock (Source: Reuters: Health)
Source: Reuters: Health - December 6, 2023 Category: Consumer Health News Source Type: news
Study shows immune molecule may play key role in the progression of ALS
Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The team also found that an immunomodulatory treatment that blocks the protein was able to restore motor function in preclinical models. The findings suggest that the protein, known as α5 integrin (pronounced alpha 5 integri n), is a potential therapeutic target for ALS. The study was… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 18, 2023 Category: Databases & Libraries Source Type: news
Road to RSNA 2023: MRI Preview
The RSNA meeting always showcases the particular benefits MRI brings to the healthcare enterprise, and this year will be no exception. One of the modality's exciting growing edges is cardiac imaging, and attendees can expect to hear a broad range of research on the topic, from how real-time MRI can be combined with deep learning to assess cardiac volumetry and how it can help clinicians "map" the effects of stroke, to using 7-tesla MRI to evaluate ventricular structure and function in patients with high blood pressure and identifying myocarditis after COVID-19 vaccination.
Along with cardiac imaging, other MRI themes at t...
Source: AuntMinnie.com Headlines - November 17, 2023 Category: Radiology Authors: Kate Madden Yee Tags: 2023 2023 MRI Preview Source Type: news
Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles
Amylyx missed Wall Street's expectations on Thursday amid struggles for its amyotrophic lateral sclerosis drug, and AMLX stock crashed. The post Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles appeared first on Investor's Business Daily.#amylyx #amlx #amylyxcrashes (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news
Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Investor Update - November 9, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Media News - November 9, 2023 Category: Pharmaceuticals Source Type: news
Botulinum Toxin Injection May Be An Option for Excess Saliva in Patients With ALS
(MedPage Today) -- PHOENIX -- Botulinum toxin injections offered relief from sialorrhea, or excessive saliva production, in patients with amyotrophic lateral sclerosis (ALS), according to a small study.
The retrospective review identified 19 veterans... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 5, 2023 Category: Neurology Source Type: news
Blood Test Measures ALS Risk From Environmental Toxins
WEDNESDAY, Nov. 1, 2023 -- Amyotrophic lateral sclerosis, better known as ALS, is debilitating and has no cure.Now, researchers at the University of Michigan have developed an environmental risk score that will allow them to assess a person ’s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 1, 2023 Category: General Medicine Source Type: news
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
- Resource consumption will be reduced by 50% to accelerate ALS development
- Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS
NEW YORK, Oct. 24, 2023 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Thera... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn, stem cell, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2023 Category: Pharmaceuticals Source Type: news
BluSky Philanthropic Event Raises $140,000 For ALS Research in St. Louis
BluSky Restoration Contractors, LLC, a leading national property restoration company in the U.S., announced it raised $140,000 for amyotrophic lateral sclerosis (ALS) research through its sixth annual Rakers Classic charity golf tournament that occurred on September 18. Funds will... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 11, 2023 Category: Pharmaceuticals Tags: CSR Source Type: news
FDA Panel Says No to Experimental ALS Drug
THURSDAY, Sept. 28, 2023 -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for amyotrophic lateral sclerosis (ALS).
Although the FDA is not... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2023 Category: Pharmaceuticals Source Type: news
